Medical Marijuana, Industrial Hemp And Cannabis Information - Hemp Gazette - Page 213

LATEST ARTICLES

Equities, Investment & Market Trends

Schumer Pushing FDA On CBD

Terry Lassitenaz - October 28, 2019

Access & Prescribing (Australia & Global)

Gibraltar Takes Another Step On The Medical Cannabis Path

Steven Gothrinet - October 25, 2019

Equities, Investment & Market Trends

Lack Of FDA Cannabidiol Regulations Rattles U.S. Consumers

Gillian Jalimnson - October 24, 2019

Global Regulatory Updates

USDA: Hemp Rules “A Couple Of Weeks” Away

Gillian Jalimnson - October 23, 2019

Australian Cannabis Policy & Law

Canberra Cannabis Stoush Continues

Steven Gothrinet - October 22, 2019

Equities, Investment & Market Trends

Hemp Thefts Skyrocket In The USA

Steven Gothrinet - October 21, 2019

Access & Prescribing (Australia & Global)

Australian Cannabusiness Roundup – October 18, 2019

Terry Lassitenaz - October 18, 2019

Australian Cannabis Policy & Law

NSW Kicks In Cash For Medicinal Cannabis Research

Terry Lassitenaz - October 17, 2019

Cannabinoid Pharmacology

Parkinson’s Patients To Participate In UK Cannabidiol Trial

Gillian Jalimnson - October 16, 2019

Access & Prescribing (Australia & Global)

Medical Cannabis For Kids – Australia’s Victoria Expands Program

Steven Gothrinet - October 15, 2019

1...212213214...316 Page 213 of 316

MOST POPULAR

Cannabinoid Pharmacology

Cannabidiol Again Shows Promise For Arthritic Dogs (And Humans)

Gillian Jalimnson - June 1, 2020

A recent study found nine out of 10 dogs with arthritis treated with CBD benefited from it - and this may have implications for...

Access & Prescribing (Australia & Global)

New Mexico Moving Ahead On Medical Cannabis Issues

Gillian Jalimnson - February 16, 2018

A couple of important developments in the U.S state of New Mexico relating to medical cannabis occurred this week.The first was a step towards...

Access & Prescribing (Australia & Global)

3 More Australian Medical Cannabis Ventures Gain Major Project Status

Gillian Jalimnson - February 4, 2020

Special status awarded to three more medicinal cannabis projects in Australia by the Morrison Government will help expedite progress on the ventures.The granting of...

Equities, Investment & Market Trends

MGC Pharmaceuticals Enters Nutraceutical Sector

Steven Gothrinet - March 15, 2018

Australian ASX-listed MGC Pharmaceuticals Ltd (ASX: MXC) has launched a nutraceutical product line called, wait for it... MGC Nutraceuticals.The term nutraceutical is a portmanteau...